Plasma amyloid β protein 1-42 levels in fetuses with Down syndrome

This result does not support the hypothesis that A β 1-42 may be related to the severity of brain damage in newborns with Down syndrome. The high levels of this peptide in fetuses without Down syndrome favour a physiological role of these peptides during brain development.